Orchestra BioMed Holdings, Inc. (OBIO) has 17 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $48K, and 3 sales totalling $172K. Most recent filing: Sept. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 11, 2026 filed Sept. 10, 2026 | Hochman David P See Remarks | $38,148 | 6,566 | −1% | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 3, 2026 | Hochman David P See Remarks | +$47,900 | 10,000 | +1% | No | |
|
|
||||||
| Sept. 2, 2026 filed Sept. 1, 2026 | Sherman Darren See Remarks | −$74,100 | 15,000 | −1% | Yes | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 26, 2026 | Taylor Andrew Lawrence Chief Financial Officer | $16,180 | 3,076 | −1% | No | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 26, 2026 | Sherman Darren See Remarks | −$15,246 | 6,925 | −59% | No | |
|
|
||||||
Showing the 5 most recent of 17 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free